LifeScience
Alphamab Oncology Initiates Phase 3 Study Of Bispecific ADC JSKN016 In Triple Negative Breast Cancer
Alphamab Oncology announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispec...
March 23, 2026 | News
MGI Tech Singapore And NUS Partner To Establish Advanced Multi Omics Laboratory For Pharmaceutical Innovation
MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Departm...
March 23, 2026 | News
Dizal Reports ZEGFROVY Achieves Superior Progression Free Survival In Phase 3 WU KONG28 Trial For EGFR Exon20ins NSCLC
Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over pla...
March 23, 2026 | News
Taiwan Strengthens Its Position In Asia’s Next Phase Of Bioprocessing Growth
Taiwan’s bioprocessing and biotechnology sector has moved from a predominantly research-and-services footing toward a more industrialised, globally c...
March 20, 2026 | Analysis
Epigenica Expands Into Japan Through PrimeTech Partnership To Advance Epigenetic Research
Epigenica AB, a company commercializing advanced tools for epigenetic analysis, announced a distribution agreement with PrimeTech Co., Ltd., a leadin...
March 20, 2026 | News
Excalipoint Therapeutics Secures 68.7 Million Dollar Seed Financing To Advance Next Generation T Cell Engager Platforms
Funding to advance proprietary T-cell engager platforms and pipeline of highly differentiated T-cell engager therapies targeting solid tumors and autoi...
March 20, 2026 | News
Pace Life Sciences Advances Digital Laboratory Operations With Labguru Platform Integration
Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U...
March 20, 2026 | News
Innorna Secures FDA Clearance For First In Class mRNA Therapy IN026 In Refractory Gout
IN026 is a potential first-in-class mRNA therapy for refractory gout, marking the emergence of a new category of mRNA medicines enabled by Innorna's propri...
March 19, 2026 | News
Everest Medicines Eyes Strategic Asia Expansion With Proposed Hasten Singapore Acquisition
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...
March 19, 2026 | News
Australia Grants CTA For First In Human KMCAR T Cell Therapy Targeting Multiple Myeloma
Clinical Trial Approval (CTA) granted by Australia’s Therapeutic Goods Administration (TGA) for KMCAR™ T-cell, a first-in-human CAR-T cell th...
March 18, 2026 | News
Akeso Secures China IND Clearance For First In Class Trispecific Antibody AK150 Targeting Solid Tumours
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has rec...
March 17, 2026 | News
Celltrion Expands US Immunology Portfolio With AVTOZMA Subcutaneous Tocilizumab Biosimilar
AVTOZMA® (tocilizumab-anoh) is among the first wave of tocilizumab biosimilars with both intravenous (IV) and subcutaneous (SC) formulations app...
March 17, 2026 | News
Vimgreen Pharmaceuticals Secures China IND Approval For VG081821 In NASH Clinical Development
Vimgreen Pharmaceuticals, a leading innovator in adenosine signaling modulation, announced the approval of its Investigational New Drug (IND) application f...
March 16, 2026 | News
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility...
March 13, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
